NCT01136824

Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 11 (actual)
• Sponsor: University of Pittsburgh · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Assessments (survey data) in this study are designed to sample the symptom burden of patients undergoing adjuvant and neoadjuvant chemotherapy in the hospital. There will be no change in the treatment plan for these patients.

Conditions

• Soft Tissue Sarcoma

Interventions

Type	Name	Description
OTHER	Questionnaires	Subjects will be given a series of questionnaires to assess the effect of AI chemotherapy, and the possible role of tumor load, on the amount of symptoms. The extent of nausea, vomiting, fatigue, anxiety, sleep disturbance, and cognitive changes will be measured. In adjuvant chemotherapy patients, we will also assess the relationship between tumor size and amount of chemotherapy-induced symptoms. These questionnaires will involve the following assessments: Demographic \& health Trait anxiety Quality of life Nausea Expectations Anxiety \& total mood disturbance Nausea \& vomiting Multiple symptoms

Timeline

• Start date: 2010-06-01
• Primary completion: 2014-05-01
• Completion: 2014-05-01
• First posted: 2010-06-03
• Last updated: 2016-07-27

Locations

1 site across 1 country: United States